Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 190

1.

Acarbose, lente carbohydrate, and prebiotics promote metabolic health and longevity by stimulating intestinal production of GLP-1.

McCarty MF, DiNicolantonio JJ.

Open Heart. 2015 Jan 29;2(1):e000205. doi: 10.1136/openhrt-2014-000205. eCollection 2015. Review.

PMID:
25685364
[PubMed]
Free PMC Article
2.

Pharmacological Interventions to Ameliorate Neuropathological Symptoms in a Mouse Model of Lafora Disease.

Berthier A, Payá M, García-Cabrero AM, Ballester MI, Heredia M, Serratosa JM, Sánchez MP, Sanz P.

Mol Neurobiol. 2015 Jan 28. [Epub ahead of print]

PMID:
25627694
[PubMed - as supplied by publisher]
3.

Metformin: A modulator of bevacizumab activity in cancer? A case report.

Indraccolo S, Randon G, Zulato E, Nardin M, Aliberti C, Pomerri F, Casarin A, Nicoletto MO.

Cancer Biol Ther. 2015 Jan 21:0. [Epub ahead of print]

PMID:
25607951
[PubMed - as supplied by publisher]
4.

The neuroprotective role of metformin in advanced glycation end product treated human neural stem cells is AMPK-dependent.

Chung MM, Chen YL, Pei D, Cheng YC, Sun B, Nicol CJ, Yen CH, Chen HM, Liang YJ, Chiang MC.

Biochim Biophys Acta. 2015 Jan 13;1852(5):720-731. doi: 10.1016/j.bbadis.2015.01.006. [Epub ahead of print]

PMID:
25595658
[PubMed - as supplied by publisher]
5.

New steroid derivative with hypoglycemic activity.

Lauro FV, Francisco DC, Lenin HH, Elodia GC, Eduardo PG, Marcela RN, Bety SA.

Int J Clin Exp Med. 2014 Nov 15;7(11):3983-91. eCollection 2014.

PMID:
25550906
[PubMed]
Free PMC Article
6.

Metformin Treatment in Post-stroke Period Prevents Nitrative Stress and Restores Angiogenic Signaling in the Brain in Diabetes.

Abdelsaid M, Prakash R, Li W, Coucha M, Hafez S, Johnson MH, Fagan SC, Ergul A.

Diabetes. 2014 Dec 18. pii: DB_141423. [Epub ahead of print]

PMID:
25524911
[PubMed - as supplied by publisher]
7.

Intracerebroventricular Metformin Decreases Body Weight But Has Pro-oxidant Effects and Decreases Survival.

Portela LV, Gnoatto J, Wigner Brochier A, Haas CB, de Assis AM, de Carvalho AK, Hansel G, Rigon Zimmer E, Oses JP, Muller AP.

Neurochem Res. 2014 Dec 10. [Epub ahead of print]

PMID:
25492133
[PubMed - as supplied by publisher]
8.

Metformin alleviates hepatosteatosis by restoring SIRT1-mediated autophagy induction via an AMP-activated protein kinase-independent pathway.

Song YM, Lee YH, Kim JW, Ham DS, Kang ES, Cha BS, Lee HC, Lee BW.

Autophagy. 2015 Jan 2;11(1):46-59. doi: 10.4161/15548627.2014.984271.

PMID:
25484077
[PubMed - in process]
9.

Pre-treatment with metformin activates Nrf2 antioxidant pathways and inhibits inflammatory responses through induction of AMPK after transient global cerebral ischemia.

Ashabi G, Khalaj L, Khodagholi F, Goudarzvand M, Sarkaki A.

Metab Brain Dis. 2014 Nov 21. [Epub ahead of print]

PMID:
25413451
[PubMed - as supplied by publisher]
10.

Galectin-3 activates PPARγ and supports white adipose tissue formation and high-fat diet-induced obesity.

Baek JH, Kim SJ, Kang HG, Lee HW, Kim JH, Hwang KA, Song J, Chun KH.

Endocrinology. 2015 Jan;156(1):147-56. doi: 10.1210/en.2014-1374.

PMID:
25343273
[PubMed - in process]
11.

Chemoquiescence for ideal cancer treatment and prevention: where are we now?

Kangwan N, Park JM, Kim EH, Hahm KB.

J Cancer Prev. 2014 Jun;19(2):89-6. doi: 10.15430/JCP.2014.19.2.89. Review.

PMID:
25337576
[PubMed]
Free PMC Article
12.

Metformin in the diabetic brain: friend or foe?

Moreira PI.

Ann Transl Med. 2014 Jun;2(6):54. doi: 10.3978/j.issn.2305-5839.2014.06.10. No abstract available.

PMID:
25333029
[PubMed]
Free PMC Article
13.

Metformin: good or bad for the brain?

Tasci I.

Ann Transl Med. 2014 Jun;2(6):53. doi: 10.3978/j.issn.2305-5839.2014.06.06. No abstract available.

PMID:
25333028
[PubMed]
Free PMC Article
14.

Metformin attenuates blood-brain barrier disruption in mice following middle cerebral artery occlusion.

Liu Y, Tang G, Li Y, Wang Y, Chen X, Gu X, Zhang Z, Wang Y, Yang GY.

J Neuroinflammation. 2014 Oct 15;11:177. doi: 10.1186/s12974-014-0177-4.

PMID:
25315906
[PubMed - in process]
Free PMC Article
15.

Metformin protects against gentamicin-induced hair cell death in vitro but not ototoxicity in vivo.

Oishi N, Kendall A, Schacht J.

Neurosci Lett. 2014 Nov 7;583:65-9. doi: 10.1016/j.neulet.2014.09.028. Epub 2014 Sep 18.

PMID:
25240593
[PubMed - in process]
16.

Modulation of the oxidative stress by metformin in the cerebrum of rats exposed to global cerebral ischemia and ischemia/reperfusion.

Abd-Elsameea AA, Moustaf AA, Mohamed AM.

Eur Rev Med Pharmacol Sci. 2014 Aug;18(16):2387-92.

PMID:
25219842
[PubMed - in process]
Free Article
17.

Metformin inhibits food intake and neuropeptide Y gene expression in the hypothalamus.

Duan Y, Zhang R, Zhang M, Sun L, Dong S, Wang G, Zhang J, Zhao Z.

Neural Regen Res. 2013 Sep 5;8(25):2379-88. doi: 10.3969/j.issn.1673-5374.2013.25.009.

PMID:
25206548
[PubMed]
Free PMC Article
18.

Chronic Metformin Preconditioning Provides Neuroprotection via Suppression of NF-κB-Mediated Inflammatory Pathway in Rats with Permanent Cerebral Ischemia.

Zhu XC, Jiang T, Zhang QQ, Cao L, Tan MS, Wang HF, Ding ZZ, Tan L, Yu JT.

Mol Neurobiol. 2014 Aug 30. [Epub ahead of print]

PMID:
25172433
[PubMed - as supplied by publisher]
19.

Glioma stem cells: markers, hallmarks and therapeutic targeting by metformin.

Najbauer J, Kraljik N, Németh P.

Pathol Oncol Res. 2014 Oct;20(4):789-97. doi: 10.1007/s12253-014-9837-z. Epub 2014 Aug 29.

PMID:
25168767
[PubMed - in process]
20.

Neuroprotective effect of metformin in MPTP-induced Parkinson's disease in mice.

Patil SP, Jain PD, Ghumatkar PJ, Tambe R, Sathaye S.

Neuroscience. 2014 Sep 26;277:747-54. doi: 10.1016/j.neuroscience.2014.07.046. Epub 2014 Aug 7.

PMID:
25108167
[PubMed - in process]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk